We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

By LabMedica International staff writers
Posted on 13 Nov 2026

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. More...

Diagnosis can be time-consuming, and collecting sputum samples may be difficult for some patients while posing risks of airborne transmission. To overcome these barriers, researchers have developed a rapid point-of-care tuberculosis test designed to provide results during a single clinic visit.

Engineers at Northwestern University developed DASH MTB, a rapid molecular test compatible with the existing DASH (Diagnostic Analyzer for Specific Hybridization) Rapid PCR system. The assay detects Mycobacterium tuberculosis, the bacterium responsible for tuberculosis, using either tongue swabs or sputum samples. Designed for point-of-care testing, the system could expand diagnostic access in remote and underserved areas where conventional laboratory services are limited.

The test uses a cartridge-based workflow that nonlaboratory personnel can perform with minimal training. Samples are prepared in three simple steps before being loaded into the analyzer for automated detection. The cartridges demonstrated storage stability at temperatures up to 45°C (113°F), potentially supporting deployment in settings with limited refrigeration, air conditioning, or reliable electricity.

The study was published on November 12 in Open Forum Infectious Diseases. The work reflects collaborations with the University of Washington, the University of Cape Town, and Stellenbosch University. According to the findings, the rapid test’s performance matched Cepheid’s Xpert MTB/RIF Ultra test, with DASH MTB reaching 100% accuracy for true-negative tests and 91% accuracy for true-positive results.

“Diagnosis is the weakest link in tuberculosis care. Tuberculosis diagnosis can be complex and time-consuming. Bacterial culture is the gold standard. It has high sensitivity, but the time-to-result is lengthy, and it is technically challenging and prone to contamination,” said Sally McFall, research professor of biomedical engineering at Northwestern’s McCormick School of Engineering and codirector of the Center for Innovation in Global Health Technologies.

“Sputum is the preferred specimen for tuberculosis diagnosis, but up to one-third of patients cannot produce sputum and thus cannot be diagnosed. Here, we tested using tongue swab specimens in addition to sputum and showed high sensitivity and specificity with both specimen types using a test that could provide the result within the clinic visit,” said McFall.

Related Links
Northwestern University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Portable POCT Blood Gas Analyzer
BD100
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.